
Sebaloxavir Marboxil Tablets Approved by NMPA—Opening a New Era of “Single-Dose Long-Lasting Protection” Against Influenza
Nanjing Zenshine Pharmaceutical Co., Ltd. has announced that its independently developed antiviral drug, Sebaloxavir Marboxil…

Nanjing Zenshine Pharmaceutical Co., Ltd. has announced that its independently developed antiviral drug, Sebaloxavir Marboxil…

Suzhou Ascentage Pharma has achieved a significant milestone with the conditional approval of Lisaftoclax Tablets…

The National Medical Products Administration (NMPA) of China has granted conditional approval for Ifupinostat Hydrochloride…

The National Medical Products Administration (NMPA) has officially approved Zeprumetostat Tablets (brand name: Airuijing, development…

As Artificial Intelligence (AI) continues to evolve, the global pharmaceutical industry is undergoing a profound…

The U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) continues…

Over the past decade, China pharmaceutical innovation has moved from “follower” to “parallel runner” and…

DengYue Medicine — Chinese biotech soars to new heights as Innovent Biologics announces a landmark…

As China’s healthcare industry continues to evolve, China medicine wholesale distributors are stepping beyond domestic…

For China drug wholesale distributors, sustainability is no longer just a slogan; it has become…